comparemela.com

Latest Breaking News On - Calliditas therapeutic - Page 3 : comparemela.com

As trial miss threatens FDA approval, Travere points to Filspari s benefits in bid to stay in kidney disease

As trial miss threatens FDA approval, Travere points to Filspari s benefits in bid to stay in kidney disease
fiercepharma.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercepharma.com Daily Mail and Mail on Sunday newspapers.

United statesJula inrigAmerican society of nephrologyTravere therapeuticsAmerican societyLeerink partnersCalliditas therapeutic

EMA endorses Calliditas Alport syndrome drug for orphan designation

EMA gives positive opinion for granting Calliditas Therapeutics’ Alport syndrome drug an orphan designation.

Lubo ivankoCompany profileEuropean commissionEuropean medicines agencyDrug administrationCompany profilesEuropean unionCalliditas therapeutic

Notice of annual general meeting of Calliditas Therapeutics AB (publ) (3)

STOCKHOLM, April 28, 2023 /PRNewswire/ The shareholders of Calliditas Therapeutics AB (publ) ("Calliditas.

United statesHenrik stenqvistHilde furbergFredrik johanssonElmar schneeMonte carloAlfred driscollStiftelsen industrifondenMolly hendersonPatrik sobocki stiftelsen industrifondenJakob grunditzEuropean commissionEuropean union member statesOxigene incSwedish companiesSwedish bar association

Notice of annual general meeting of Calliditas Therapeutics AB (publ)

STOCKHOLM, April 28, 2023 /PRNewswire/ The shareholders of Calliditas Therapeutics AB (publ) ("Calliditas Therapeutics"), Reg. No. 556659-9766, with registered office in Stockholm, are summoned

United statesJakob grunditzAlfred driscollFredrik johanssonMonte carloMolly hendersonElmar schneeHenrik stenqvistStiftelsen industrifondenPatrik sobocki stiftelsen industrifondenHilde furbergEuropean commissionRemuneration committeeEuropean union member statesOxigene incSwedish companies registration office

Notice of annual general meeting of Calliditas Therapeutics AB (publ) (4)

STOCKHOLM, April 28, 2023 /PRNewswire/ The shareholders of Calliditas Therapeutics AB (publ) ("Calliditas.

United statesStiftelsen industrifondenAlfred driscollMonte carloElmar schneeHilde furbergFredrik johanssonHenrik stenqvistJakob grunditzPatrik sobocki stiftelsen industrifondenMolly hendersonSwedish bar associationSwedish companiesOxigene incEuropean union member statesEuropean commission

vimarsana © 2020. All Rights Reserved.